{"id":33730,"date":"2026-02-25T09:05:00","date_gmt":"2026-02-25T14:05:00","guid":{"rendered":"https:\/\/genomequebec.com\/?p=33730"},"modified":"2026-03-20T17:59:53","modified_gmt":"2026-03-20T21:59:53","slug":"over-4-3-million-in-funding-to-advance-genomic-solutions-in-precision-medicine","status":"publish","type":"post","link":"https:\/\/genomequebec.com\/en\/news-and-publications\/over-4-3-million-in-funding-to-advance-genomic-solutions-in-precision-medicine\/","title":{"rendered":"Over $4.3 million in funding to advance genomic solutions in precision medicine"},"content":{"rendered":"\n<p><strong>Montr\u00e9al, February 25, 2026<\/strong> \u2013 G\u00e9nome Qu\u00e9bec is proud to announce funding for 12 new innovative research projects through its <em>Genomics Integration Program in Human Health.<\/em> Led by researchers from Qu\u00e9bec universities, these initiatives will harness genomics to tackle health challenges. Over $4.3 million, including contributions from public and private partners, has been invested in this fifth round of the program.<\/p>\n\n\n\n<p>With a focus on precision medicine, including RNA-based approaches, the selected projects bring together expertise from the research community and both the private and public sectors. Drawing on advances in genomics, they aim to drive innovation and support its integration into clinical and operational settings. This research will pave the way to real-world applications in prevention, diagnosis and treatment and will help improve the management of conditions associated with significant public health challenges, including cancer and rare diseases.<\/p>\n\n\n\n<p>\u201cThese projects highlight the ability of Qu\u00e9bec\u2019s research community to address complex health challenges through innovative and rigorous approaches. By supporting proof-of-concept projects that are ready for integration or commercialization, G\u00e9nome Qu\u00e9bec maximizes the impact of public funding and strengthens scientific autonomy,\u201d explained <strong>St\u00e9phanie Lord-Fontaine, Vice President of Scientific Affairs at G\u00e9nome Qu\u00e9bec.<\/strong><\/p>\n\n\n\n<p><strong>Congratulations to the recipients<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Olivier Barbier from Universit\u00e9 Laval in partnership with Trienix Pharma inc. &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/targeting-gut-microbiota-to-treat-metabolic-and-autoimmune-liver-diseases-a-promising-approach-for-treatment-and-commercialization\/\" target=\"_blank\" rel=\"noreferrer noopener\">Targeting gut microbiota to treat metabolic and autoimmune liver diseases: a promising approach for treatment and commercialization<\/a><\/li>\n\n\n\n<li>\u00c9milie B\u00e9dard from Polytechnique Montr\u00e9al in partnership with the Ville de Qu\u00e9bec \u2013 Service du traitement des eaux &#8211; <a href=\"https:\/\/genomequebec.com\/en\/funded-projects\/studying-airborne-bacteria-in-wastewater-treatment-plants-to-better-protect-workers-health\/\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/genomequebec.com\/en\/funded-projects\/studying-airborne-bacteria-in-wastewater-treatment-plants-to-better-protect-workers-health\/\" rel=\"noreferrer noopener\">Studying airborne bacteria in wastewater treatment plants to better protect workers\u2019 health<\/a><\/li>\n\n\n\n<li>Sonia Cellot from Universit\u00e9 de Montr\u00e9al in partnership with CHU Sainte-Justine &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/plasma-protein-profiling-to-improve-non-invasive-diagnosis-and-monitoring-of-children-with-leukemia\/\" target=\"_blank\" rel=\"noreferrer noopener\">Plasma protein profiling to improve non-invasive diagnosis and monitoring of children with leukemia<\/a><\/li>\n\n\n\n<li>Alexandre Pellan Cheng from \u00c9cole de technologie sup\u00e9rieure in partnership with OPTILAB CHUM &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/search-and-rescue-detecting-cancer-with-a-blood-test-for-all-patients\/\" target=\"_blank\" rel=\"noreferrer noopener\">Search and rescue: detecting cancer with a blood test for all patients<\/a><\/li>\n\n\n\n<li>Bruno Gaillet from Universit\u00e9 Laval in partnership with the National Research Council Canada &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/development-of-new-sequencing-tools-for-accurate-analysis-of-genetic-material-inside-virus-based-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Development of new sequencing tools for accurate analysis of genetic material inside virus-based therapies<\/a><\/li>\n\n\n\n<li>Soren Gantt from McGill University in partnership with Merck &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/evaluating-the-specificity-of-a-method-to-detect-antibody-responses-to-a-whole-virus-replication-defective-cmv-vaccine\/\" target=\"_blank\" rel=\"noreferrer noopener\">Evaluating the specificity of a method to detect antibody responses to a whole virus replication-defective CMV vaccine<\/a><\/li>\n\n\n\n<li>\u00c9ric L\u00e9cuyer from Universit\u00e9 de Montr\u00e9al in partnership with RNA Technologies &amp; Therapeutics &#8211; <a href=\"https:\/\/genomequebec.com\/en\/funded-projects\/exploring-the-potential-of-circular-rnas-as-cancer-therapeutics\/\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/genomequebec.com\/en\/funded-projects\/exploring-the-potential-of-circular-rnas-as-cancer-therapeutics\/\" rel=\"noreferrer noopener\">Exploring the potential of circular RNAs as cancer therapeutics<\/a><\/li>\n\n\n\n<li>Peter Metrakos from McGill University in partnership with Roche Diagnostics &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/using-digital-pcr-to-improve-care-for-colorectal-cancer-patients-with-liver-metastases\/\" target=\"_blank\" rel=\"noreferrer noopener\">Using digital PCR to improve care for colorectal cancer patients with liver metastases<\/a><\/li>\n\n\n\n<li>John D. Rioux from Universit\u00e9 de Montr\u00e9al in partnership with Crohn\u2019s and Colitis Canada &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/response-to-therapy-r2t-in-inflammatory-bowel-disease\/\" target=\"_blank\" rel=\"noreferrer noopener\">Response to therapy (R2T) in inflammatory bowel disease<\/a><\/li>\n\n\n\n<li>Rima Slim from McGill University in partnership with OPTILAB CUSM &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/precision-medicine-in-genomic-diagnosis-of-female-infertility-a-proof-of-concept\/\" target=\"_blank\" rel=\"noreferrer noopener\">Precision medicine in genomic diagnosis of female infertility: a proof of concept<\/a><\/li>\n\n\n\n<li>Paul J. Thomassin from McGill University in partnership with the Public Health Agency of Canada &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/using-genome-sequencing-to-estimate-the-health-and-economic-impact-of-foodborne-drug-resistant-pathogens\/\" target=\"_blank\" rel=\"noreferrer noopener\">Using genome sequencing to estimate the health and economic impact of foodborne drug-resistant pathogens<\/a><\/li>\n\n\n\n<li>Donald C. Vinh from McGill University in partnership with Illumina &#8211; <a href=\"https:\/\/genomequebec.com\/en\/financed-project\/long-read-based-whole-genome-sequencing-for-rare-disease-diagnosis-a-pilot-study\/\" target=\"_blank\" rel=\"noreferrer noopener\">Long read-based whole genome sequencing for rare disease diagnosis: A pilot study<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>What is the <em>Genomics Integration Program \u2013 Human Health<\/em>?<\/strong><\/p>\n\n\n\n<p>This program provides project funding ranging from $100,000 to $400,000, covering half of the cost of partnerships between academic researchers and user partners capable of implementing or commercializing research results. The funds invested will be used to establish a proof of concept with the potential for subsequent funding or to integrate the results of the proof of concept by the user partner at the end of the project. Finally, projects must be related to human health and include an aspect of omics technology, for example, the development of new omics technologies, the use of AI-driven omics data, genetic engineering, synthetic biology, the validation of therapeutic targets or biomarkers identified through genomics.<\/p>\n\n\n\n<p><strong>About G\u00e9nome Qu\u00e9bec<\/strong><\/p>\n\n\n\n<p>G\u00e9nome Qu\u00e9bec\u2019s mission is to catalyze the development and excellence of genomics research and promote its integration and democratization. It is a pillar of the Qu\u00e9bec bioeconomy and contributes to Qu\u00e9bec\u2019s influence and its social and sustainable development. The funds invested by G\u00e9nome Qu\u00e9bec are provided by the Minist\u00e8re de l&#8217;\u00c9conomie, de l&#8217;Innovation et de l\u2019\u00c9nergie du Qu\u00e9bec (MEIE), the government of Canada, through Genome Canada,&nbsp;and private partners. To learn more, visit <a href=\"https:\/\/genomequebec.com\/en\/\">genomequebec.com\/en\/<\/a>.<\/p>\n\n\n\n<p class=\"has-text-align-center\">-30-<\/p>\n\n\n\n<p><strong>Contact<\/strong><\/p>\n\n\n\n<p style=\"margin-top:0;margin-bottom:0;padding-top:0;padding-right:0;padding-bottom:0;padding-left:0\">Antoine Gascon<br>Specialist, Communications and Digital Media<\/p>\n\n\n\n<p style=\"margin-top:0;margin-bottom:0;padding-top:0;padding-right:0;padding-bottom:0;padding-left:0\">514-377-5613<br><a href=\"mailto:agascon@genomequebec.com\" target=\"_blank\" rel=\"noreferrer noopener\">agascon@genomequebec.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Montr\u00e9al, February 25, 2026 \u2013 G\u00e9nome Qu\u00e9bec is proud to announce funding for 12 new innovative research projects through its Genomics Integration Program in Human Health. Led by researchers from&hellip;<\/p>\n","protected":false},"author":2,"featured_media":33746,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"16579,16778,16543,16834,28431,16721","_relevanssi_noindex_reason":"","footnotes":""},"categories":[295],"tags":[],"class_list":["post-33730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/33730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/comments?post=33730"}],"version-history":[{"count":6,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/33730\/revisions"}],"predecessor-version":[{"id":33850,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/33730\/revisions\/33850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media\/33746"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=33730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/categories?post=33730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/tags?post=33730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}